Access cutting-edge crohn's disease treatment through this clinical trial at a research site in Lancaster. Study-provided care at no cost to qualified participants.
Access crohn's disease specialists in Lancaster at no cost
This study follows strict safety protocols and ethical guidelines
All study-related crohn's disease treatment provided free
This Phase III, multicenter, double-blind, placebo-controlled treat-through study will evaluate the efficacy and safety of induction and maintenance therapy with Afimkibart (also known as RO7790121) in participants with moderately to severely active Crohn's disease (CD).
Sponsor: Hoffmann-La Roche
Check if you qualify for this crohn's disease clinical trial in Lancaster, CA
If you're searching for crohn's disease treatment options in Lancaster, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Lancaster research site is actively enrolling participants for this clinical trial. You'll receive care from experienced crohn's disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.